Literature DB >> 17942494

Oropharyngeal dysphagia: the experience of patients with non-head and neck cancers receiving specialist palliative care.

Justin W G Roe1, Paula Leslie, Michael J Drinnan.   

Abstract

BACKGROUND: Difficulty swallowing is a well-documented symptom in head and neck cancer and oesophageal malignancy. The frequency of oropharyngeal swallowing difficulties in the palliative phase of other malignancies is less reported. AIM: 1) To describe the patient experience of swallowing and associated difficulties while receiving specialist palliative care for malignancies other than those affecting the head and neck and 2) to identify the quality of life issues for the participants with dysphagia and compare with normative and dysphagic data provided by SWAL-QOL.
DESIGN: Four month prospective pilot study - questionnaire design.
SETTING: Acute teaching hospital. PARTICIPANTS: Eleven patients receiving specialist palliative care.
METHODS: Participants were interviewed using a modified version of the SWAL-QOL, a validated quality of life assessment tool for use specifically with people with oropharyngeal dysphagia. Eight quality of life domains were explored as well as fourteen dysphagic symptoms.
RESULTS: Seven of the 11 participants had dysphagic symptoms detailed in the SWAL-QOL and a further two patients reported transient dysphagic symptoms since diagnosis of their disease. Nine participants reported an impact on their quality of life and three reported a considerable impact in four or more domains. Eight of the 11 participants had self-selected softer textured foods. A notable group were three patients with lung cancer and one with lung metastases with a history of vocal fold motion impairment, all of who had experienced dysphagic symptoms since diagnosis.
CONCLUSIONS: Patients with cancers not affecting the head and neck are at risk of developing symptoms of oropharyngeal dysphagia and subsequently, compromized nutrition, hydration and quality of life. Areas for further research are suggested.

Entities:  

Mesh:

Year:  2007        PMID: 17942494     DOI: 10.1177/0269216307082656

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  7 in total

1.  Cross-cultural adaptation and validation of the Dutch version of SWAL-QoL.

Authors:  H C A Bogaardt; R Speyer; L W J Baijens; W J Fokkens
Journal:  Dysphagia       Date:  2008-07-15       Impact factor: 3.438

2.  Oropharyngolaryngeal disorders in scleroderma: development and validation of the SLS scale.

Authors:  Chiara Vitali; Elisa Borghi; Arianna Napoletano; Francesca Polini; Monica Caronni; Paola Ammenti; Davide Cattaneo
Journal:  Dysphagia       Date:  2009-08-26       Impact factor: 3.438

3.  Swallowing problems at the end of the palliative phase: incidence and severity in 164 unsedated patients.

Authors:  Hans Bogaardt; Laetitia Veerbeek; Katherine Kelly; Agnes van der Heide; Lia van Zuylen; Renée Speyer
Journal:  Dysphagia       Date:  2014-12-23       Impact factor: 3.438

4.  Assessment of swallowing function impairment in patients with benign goiters and impact of thyroidectomy: a case control study.

Authors:  Mayilvaganan Sabaretnam; Anjali Mishra; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

5.  An investigation of the prevalence of swallowing difficulties and impact on quality of life in patients with advanced lung cancer.

Authors:  Grainne C Brady; Justin W G Roe; Mary O' Brien; Annette Boaz; Clare Shaw
Journal:  Support Care Cancer       Date:  2017-09-02       Impact factor: 3.603

6.  Oropharyngeal Dysphagia Evaluation Tools in Adults with Solid Malignancies Outside the Head and Neck and Upper GI Tract: A Systematic Review.

Authors:  Ciarán Kenny; Órla Gilheaney; Declan Walsh; Julie Regan
Journal:  Dysphagia       Date:  2018-04-02       Impact factor: 3.438

7.  Cross-cultural adaption and validation of the Persian version of the SWAL-QOL.

Authors:  Maryam Tarameshlu; Amir Reza Azimi; Shohreh Jalaie; Leila Ghelichi; Noureddin Nakhostin Ansari
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.